PART I OVERVIEW We are a global life sciences company focused on providing innovative preparedness and response solutions addressing accidental, deliberate and naturally occurring Public Health Threats (PHTs). Our solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing (CDMO) services portfolio. The types of PHTs we are currently addressing are focused on the following four categories: chemical, biological, radiological, nuclear and ex...
Q2 FY2026 — expected 2026-09-06
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-27 | 2025-12-31 | 0001367644-26-000015 | EDGAR | 88K words |
| 2025-03-04 | 2024-12-31 | 0001367644-25-000021 | EDGAR | — |
| 2024-03-08 | 2023-12-31 | 0001367644-24-000033 | EDGAR | — |
| 2023-03-01 | 2022-12-31 | 0001367644-23-000046 | EDGAR | — |
| 2022-02-25 | 2021-12-31 | 0001367644-22-000024 | EDGAR | — |
| 2021-02-19 | 2020-12-31 | 0001367644-21-000033 | EDGAR | — |
| 2020-02-25 | 2019-12-31 | 0001367644-20-000010 | EDGAR | — |
| 2019-02-22 | 2018-12-31 | 0001367644-19-000016 | EDGAR | — |
| 2018-02-23 | 2017-12-31 | 0001367644-18-000014 | EDGAR | — |
| 2017-02-28 | 2016-12-31 | 0001367644-17-000014 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-10-30 | 2025-09-30 | 0001367644-25-000202 | EDGAR | 37K words |
| 2025-08-07 | 2025-06-30 | 0001367644-25-000181 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001367644-25-000124 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001367644-24-000178 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0001367644-24-000147 | EDGAR | — |
| 2024-05-02 | 2024-03-31 | 0001367644-24-000063 | EDGAR | — |
| 2023-12-11 | 2023-09-30 | 0001367644-23-000208 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001367644-23-000155 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001367644-23-000088 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001367644-22-000144 | EDGAR | — |
| 2022-08-02 | 2022-06-30 | 0001367644-22-000119 | EDGAR | — |
| 2022-04-29 | 2022-03-31 | 0001367644-22-000070 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-03 | 0001367644-26-000019 | EDGAR | 1K words |
| 2026-02-26 | 0001367644-26-000012 | EDGAR | — |
| 2026-01-14 | 0001193125-26-013061 | EDGAR | — |
| 2026-01-12 | 0001367644-26-000003 | EDGAR | — |
| 2025-12-12 | 0001367644-25-000207 | EDGAR | — |
| 2025-11-12 | 0001367644-25-000204 | EDGAR | — |
| 2025-10-29 | 0001367644-25-000198 | EDGAR | — |
| 2025-09-11 | 0001367644-25-000188 | EDGAR | — |
| 2025-09-05 | 0001367644-25-000183 | EDGAR | — |
| 2025-08-06 | 0001367644-25-000179 | EDGAR | — |
270 total filings indexed. 238 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001367644 |
| Ticker | EBS |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.emergentbiosolutions.com |
| Listed | 2006-11-15 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report